Empower Advisory Group, LLC Astrazeneca PLC Transaction History
Empower Advisory Group, LLC
- $35.9 Billion
- Q3 2025
A detailed history of Empower Advisory Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Empower Advisory Group, LLC holds 5,523 shares of AZN stock, worth $493,756. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,523
Previous 5,008
10.28%
Holding current value
$493,756
Previous $349,000
21.2%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...